Congress trades
Exact Sciences Corporation (EXAS)
Free on iOS and Android.
About Exact Sciences Corporation
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- Kevin T. Conroylast on record
- Employees
- 6,900
- Listed since
- Feb 1, 2001
- Market value
- $20.0Blast quoted Mar 23, 2026
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2025reported Feb 13, 2026 | -$0.45 | -$0.11 | $878.4M | $860.9M | EPS missRevenue beat |
| Q3 FY2025reported Nov 3, 2025 | $0.24 | -$0.06 | $850.7M | $810.5M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 6, 2025 | $0.22 | -$0.02 | $811.1M | $810.1M | EPS beatRevenue in line |
| Q1 FY2025reported May 1, 2025 | -$0.54 | -$0.37 | $706.8M | $688.6M | EPS missRevenue beat |
| Q4 FY2024reported Feb 19, 2025 | -$0.06 | -$0.29 | $713.4M | $697.9M | EPS beatRevenue beat |
| Q3 FY2024reported Nov 5, 2024 | -$0.21 | -$0.20 | $708.7M | $716.8M | EPS missRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2024 · proxy filed Apr 29, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Kevin ConroyChairman, President and Chief Executive Officer | $1.1M | $13.5M | $960K | $15.5M |
| Aaron BloomerExecutive Vice President and Chief Financial Officer | $432K | $6.0M | $752K | $7.2M |
| Jacob OrvilleExecutive Vice President and General Manager, Screening | $618K | $3.6M | $234K | $4.4M |
| Brian BaranickExecutive Vice President and General Manager, Precision Oncology | $600K | $3.6M | $218K | $4.4M |
| Sarah CondellaExecutive Vice President, Human Resources | $509K | $1.9M | $226K | $2.6M |
The summary compensation table from the proxy statement for fiscal 2024, with titles as filed then. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in EXAS
20 disclosures of 28 on record · median 28d of the 45 allowedSince the trade: the stock's move from the trade date to the last close under this ticker (Mar 23, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Kevin HernDependent child | Stock | Sale | $1,001 - $15,000 | n/a | Mar 24, 2026 | Apr 3, 2026 | 10d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +96.1%After the saleS&P 500 +24.9% · +71.2 pts vs S&P 500 | May 10, 2024 | Jun 8, 2024 | 29d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +64.1%After the saleS&P 500 +33.0% · +31.1 pts vs S&P 500 | Feb 1, 2024 | Mar 7, 2024 | 35d |
| Kevin HernDependent child | Stock | Sale | $1,001 - $15,000 | +42.2%After the saleS&P 500 +37.8% · +4.4 pts vs S&P 500 | Jan 2, 2024 | Feb 11, 2024 | 40d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +77.0%After the saleS&P 500 +47.8% · +29.2 pts vs S&P 500 | Nov 13, 2023 | Dec 8, 2023 | 25d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +56.8%S&P 500 +49.3% · +7.5 pts vs S&P 500 | Oct 16, 2023 | Nov 11, 2023 | 26d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +36.8%After the saleS&P 500 +46.3% · -9.5 pts vs S&P 500 | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +65.5%After the saleS&P 500 +56.6% · +8.8 pts vs S&P 500 | May 1, 2023 | Jun 11, 2023 | 41d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +53.8%S&P 500 +64.4% · -10.6 pts vs S&P 500 | Jan 20, 2023 | Feb 17, 2023 | 28d |
| Kevin HernJoint | Stock | Sale | $1,001 - $15,000 | +55.4%After the saleS&P 500 +60.1% · -4.7 pts vs S&P 500 | Jan 31, 2023 | Feb 14, 2023 | 14d |
| Kevin HernJoint | Stock | Sale | $50,001 - $100,000 | +109.8%After the saleS&P 500 +70.5% · +39.4 pts vs S&P 500 | Dec 19, 2022 | Jan 13, 2023 | 25d |
| Kevin HernDependent child | Stock | Sale | $1,001 - $15,000 | +107.5%After the saleS&P 500 +62.6% · +45.0 pts vs S&P 500 | May 16, 2022 | Jun 14, 2022 | 29d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -2.8%After the saleS&P 500 +55.3% · -58.1 pts vs S&P 500 | Jun 3, 2021 | Jul 15, 2021 | 42d |
| Kevin HernJoint | Stock | Purchase | $50,001 - $100,000 | -0.8%S&P 500 +56.6% · -57.4 pts vs S&P 500 | May 20, 2021 | Jun 15, 2021 | 26d |
| Kevin HernDependent child | Stock | Purchase | $1,001 - $15,000 | -0.8%S&P 500 +56.6% · -57.4 pts vs S&P 500 | May 20, 2021 | Jun 15, 2021 | 26d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -15.0%S&P 500 +82.5% · -97.5 pts vs S&P 500 | Nov 11, 2020 | Dec 9, 2020 | 28d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -1.6%S&P 500 +91.8% · -93.3 pts vs S&P 500 | Oct 26, 2020 | Nov 5, 2020 | 10d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +37.2%After the saleS&P 500 +91.3% · -54.1 pts vs S&P 500 | Sep 15, 2020 | Oct 13, 2020 | 28d |
| Kevin HernJoint | Stock | Purchase | $1,001 - $15,000 | +8.8%S&P 500 +101.4% · -92.5 pts vs S&P 500 | Jul 27, 2020 | Aug 15, 2020 | 19d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +21.7%After the saleS&P 500 +111.1% · -89.4 pts vs S&P 500 | Jun 2, 2020 | Jul 9, 2020 | 37d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in EXAS, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded EXAS?
Kevin Hern and Josh Gottheimer disclosed EXAS transactions in the filings shown here.
How quickly are EXAS trades disclosed?
Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.